{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T06:39:57Z","timestamp":1769150397174,"version":"3.49.0"},"reference-count":29,"publisher":"Scientific Scholar","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,12]]},"abstract":"\n Background & objectives:<\/jats:title>\n Hepatic venous malformation gradually develops over time and exhibits the malignant biological behaviours of being locally invasive, causing morphological and functional damage to local tissue, and may even cause systemic coagulopathy. Studies show that galectin-3(Gal-3) expression is closely associated with local invasion of malignant tumours. In this study an attempt was made to assess the clinical significance of Gal-3 in local invasion during hepatic venous malformation in patients.<\/jats:p>\n <\/jats:sec>\n \n Methods:<\/jats:title>\n Gal-3 protein and its mRNA expression were examined using immunohistochemistry and in situ<\/jats:italic> hybridization in a total of 126 patients with hepatic venous malformation. For control tissue, 20 cases of normal tissue distal to surgical margins were also examined. In addition, the association between Gal-3 expression and pathological parameters was analyzed in hepatic venous malformation patients.<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n Gal-3 mRNA positivity was observed in 65.08 per cent (82\/126) of hepatic venous malformation tissue samples, which was higher than the rate of 20 per cent (4\/20) (P<\/jats:italic><0.05) seen in control tissues. Gal-3 protein positivity was observed in 58.73 per cent (74\/126) of hepatic venous malformation tissue samples, which was higher than the rate of 15 per cent (3\/20) (P<\/jats:italic><0.05) seen in the normal tissue. Gal-3 expression was not significantly associated with age or gender. However, there was a significant association between Gal-3 positivity and lesion size, local invasion depth, and involvement with the hepatic vein and the portal system.<\/jats:p>\n <\/jats:sec>\n \n Interpretation & conclusions:<\/jats:title>\n Local tissue invasion and destruction by hepatic venous malformation may be related to the upregulation of Gal-3. Gal-3 expression and the development of venous malformation may be related and needs to be studied further.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/ijmr.ijmr_500_17","type":"journal-article","created":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T13:43:27Z","timestamp":1549979007000},"page":"728-733","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Clinical significance of galectin-3 expression in malformed hepatic venous tissue"],"prefix":"10.25259","volume":"148","author":[{"given":"Junbo","family":"Qiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changxian","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","reference":[{"key":"R1-10-20241212","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00106-013-2805-1","article-title":"Venous and arteriovenous malformations in the head and neck region. Therapeutic options and challenges","volume":"62","author":"Eivazi","year":"2014","journal-title":"HNO"},{"key":"R2-10-20241212","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.4103\/0366-6999.164987","article-title":"Analysis and treatment of multiple severe venous vascular malformation syndrome combined with coagulopathy","volume":"128","author":"Qiao","year":"2015","journal-title":"Chin Med J (Engl"},{"key":"R3-10-20241212","doi-asserted-by":"crossref","first-page":"942","DOI":"10.3109\/00016480903555408","article-title":"Orbital and periorbital vascular anomalies- an approach to diagnosis and therapeutic concepts","volume":"130","author":"Eivazi","year":"2010","journal-title":"Acta Otolaryngol"},{"key":"R4-10-20241212","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1258\/phleb.2009.009041","article-title":"Venous malformation: Update on aetiopathogenesis, diagnosis and management","volume":"25","author":"Dompmartin","year":"2010","journal-title":"Phlebology"},{"key":"R5-10-20241212","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1258\/phleb.2011.011029","article-title":"Phleboliths from venous malformations of the head and neck","volume":"28","author":"Eivazi","year":"2013","journal-title":"Phlebology"},{"key":"R6-10-20241212","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/hae.13061","article-title":"Management of congenital quantitative fibrinogen disorders: A Delphi consensus","volume":"22","author":"Casini","year":"2016","journal-title":"Haemophilia"},{"key":"R7-10-20241212","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S0092-8674(00)81814-0","article-title":"Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2","volume":"87","author":"Vikkula","year":"1996","journal-title":"Cell"},{"key":"R8-10-20241212","first-page":"235","article-title":"Galectin expression in cancer diagnosis and prognosis: A systematic review","volume":"1855","author":"Thijssen","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"R9-10-20241212","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.4103\/0366-6999.211537","article-title":"Pingyangmycin pretreatment influences the biological behavior of ocular venous malformation and relates with galectin-3 expression","volume":"130","author":"Li","year":"2017","journal-title":"Chin Med J (Engl"},{"key":"R10-10-20241212","doi-asserted-by":"crossref","first-page":"e1100","DOI":"10.1038\/cddis.2014.68","article-title":"Galectin-3 is a marker of favorable prognosis and a biologically relevant molecule in neuroblastic tumors","volume":"5","author":"Veschi","year":"2014","journal-title":"Cell Death Dis"},{"key":"R11-10-20241212","first-page":"1307","article-title":"Increased expression of galectin-3 in primary gastric cancer and the metastatic lymph nodes","volume":"9","author":"Miyazaki","year":"2002","journal-title":"Oncol Rep"},{"key":"R12-10-20241212","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1148\/radiology.192.2.8029404","article-title":"Hepatic hemangiomas: A multi-institutional study of appearance on T2-weighted and serial gadolinium-enhanced gradient-echo MR images","volume":"192","author":"Semelka","year":"1994","journal-title":"Radiology"},{"key":"R13-10-20241212","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2214\/ajr.168.2.9016227","article-title":"Hepatic cavernous hemangioma: Appearance on T2-weighted fast spin-echo MR imaging with and without fat suppression","volume":"168","author":"Soyer","year":"1997","journal-title":"AJR Am J Roentgenol"},{"key":"R14-10-20241212","first-page":"70","article-title":"Surgical management of giant hepatic hemangiomas: Complications and review of the literature","volume":"35","author":"Ho","year":"2012","journal-title":"Chang Gung Med J"},{"key":"R15-10-20241212","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1001\/jamasurg.2014.477","article-title":"Assessing normal growth of hepatic hemangiomas during long-term follow-up","volume":"149","author":"Hasan","year":"2014","journal-title":"JAMA Surg"},{"key":"R16-10-20241212","doi-asserted-by":"crossref","first-page":"227.e1","DOI":"10.1016\/j.jpurol.2015.03.019","article-title":"Genitourinary and perineal vascular anomalies in children: A Seattle children's experience","volume":"11","author":"Willihnganz-Lawson","year":"2015","journal-title":"J Pediatr Urol"},{"key":"R17-10-20241212","doi-asserted-by":"crossref","first-page":"16","DOI":"10.14309\/crj.2014.70","article-title":"Hereditary hemorrhagic telangiectasia with liver vascular malformation presenting with high-output heart failure","volume":"2","author":"Singh","year":"2014","journal-title":"ACG Case Rep J"},{"key":"R18-10-20241212","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1007\/s00247-015-3389-6","article-title":"MRI phenotypes of localized intravascular coagulopathy in venous malformations","volume":"45","author":"Koo","year":"2015","journal-title":"Pediatr Radiol"},{"key":"R19-10-20241212","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1001\/archderm.144.7.873","article-title":"Association of localized intravascular coagulopathy with venous malformations","volume":"144","author":"Dompmartin","year":"2008","journal-title":"Arch Dermatol"},{"key":"R20-10-20241212","first-page":"156","article-title":"The role of galectin-3 in \u03b1-synuclein-induced microglial activation","volume":"2","author":"Boza-Serrano","year":"2014","journal-title":"Acta Neuropathol Commun"},{"key":"R21-10-20241212","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1124\/jpet.114.218370","article-title":"Functions of galectin-3 and its role in fibrotic diseases","volume":"351","author":"Li","year":"2014","journal-title":"J Pharmacol Exp Ther"},{"key":"R22-10-20241212","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1916-0216-42-16","article-title":"Serum biomarkers of papillary thyroid cancer","volume":"42","author":"Makki","year":"2013","journal-title":"J Otolaryngol Head Neck Surg"},{"key":"R23-10-20241212","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1182\/blood-2014-04-569939","article-title":"The role of galectin-3 and galectin-3-binding protein in venous thrombosis","volume":"125","author":"DeRoo","year":"2015","journal-title":"Blood"},{"key":"R24-10-20241212","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1074\/jbc.M606862200","article-title":"Galectin-3 interaction with Thomsen-Friedenreich disaccharide on cancer-associated MUC1 causes increased cancer cell endothelial adhesion","volume":"282","author":"Yu","year":"2007","journal-title":"J Biol Chem"},{"key":"R25-10-20241212","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000365673","article-title":"Diagnostic and prognostic significance of serum and tissue galectin 3 expression in patients with carcinoma of the bladder","volume":"7","author":"Gendy","year":"2014","journal-title":"Curr Urol"},{"key":"R26-10-20241212","first-page":"69","article-title":"Expression of galectin-3 in gastric adenocarcinoma","volume":"140","author":"Gomes","year":"2014","journal-title":"Indian J Med Res"},{"key":"R27-10-20241212","first-page":"669","article-title":"Galectin-3 concentration in liver diseases","volume":"45","author":"Gudowska","year":"2015","journal-title":"Ann Clin Lab Sci"},{"key":"R28-10-20241212","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3748\/wjg.v8.i1.5","article-title":"Changing patterns of traumatic bile duct injuries: A review of forty years experience","volume":"8","author":"Huang","year":"2002","journal-title":"World J Gastroenterol"},{"key":"R29-10-20241212","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12974-015-0312-x","article-title":"Who let the dogs out? Detrimental role of galectin-3 in hypoperfusion-induced retinal degeneration","volume":"12","author":"Manouchehrian","year":"2015","journal-title":"J Neuroinflammation"}],"container-title":["Indian Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/02223309-201848060-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T13:52:49Z","timestamp":1751464369000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/02223309-201848060-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.4103\/ijmr.ijmr_500_17","relation":{},"ISSN":["0971-5916"],"issn-type":[{"value":"0971-5916","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]}}}